Completion of the combination between Novozymes and Chr. Hansen
29 janv. 2024 05h27 HE
|
Chr. Hansen Holding A/S
January 29, 2024 – Company announcement no. 2 Please see attachment. CONTACT INFORMATION Investor Relations Tobias Cornelius Bjorklund +45 3077 8682...
All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
26 janv. 2024 06h09 HE
|
Chr. Hansen Holding A/S
January 26, 2024 – Company announcement no. 1 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038...
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted
20 déc. 2023 09h02 HE
|
Chr. Hansen Holding A/S
December 20, 2023 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com Press RelationsSanne Seyer-Hansen+45 6038...
Major shareholder announcement from Burlington Loan Management DAC
19 déc. 2023 05h54 HE
|
Chr. Hansen Holding A/S
December 19, 2023 – Company announcement no. 12 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com Press...
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained
12 déc. 2023 11h11 HE
|
Chr. Hansen Holding A/S
December 12, 2023 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com Press RelationsSanne...
Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.
20 nov. 2023 02h03 HE
|
Chr. Hansen Holding A/S
November 20, 2023 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press RelationsSanne Seyer-Hansen+45 6038...
Managers' Transaction
02 nov. 2023 08h10 HE
|
Chr. Hansen Holding A/S
November 2, 2023 - Announcement No. 11 Vesting of restricted share units Chr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below...
Managers' Transactions
13 oct. 2023 09h16 HE
|
Chr. Hansen Holding A/S
October 13, 2023 - Announcement No. 10 Vesting of shares Chr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below...
Chr. Hansen Holding A/S Interim Report Q4 2022/23
12 oct. 2023 02h02 HE
|
Chr. Hansen Holding A/S
October 12, 2023 – Company announcement no. 9 Strong performance for the quarter despite a challenging environment Statement by CEO Mauricio Graber: “Supported by a strong Q4 performance, Chr....
Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen
10 oct. 2023 02h08 HE
|
Chr. Hansen Holding A/S
October 10, 2023 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press...